Posted on 3/18/20
Most Aggressive States Against the Coronavirus – WalletHub Study
According to the World Health Organization, the primary way that coronavirus (COVID-19) spreads is through close interaction with other people. If people come into contact with . . .
Posted on 3/17/20
Keros Therapeutics Starts U.S. IPO Effort Amid Market Turmoil
Keros Therapeutics (KROS) has filed to raise $86.25 million in an IPO of its common stock, according to an S-1 registration statement.The firm is a clinical . . .
Posted on 3/17/20
Avalere Health Partners With Corrona
Avalere, an Inovalon company specializing in healthcare research and strategic advisory services, has entered into a collaboration with Corrona, a leader in real-world evidence generation in . . .
Posted on 3/17/20
Vaxxas Awarded $5M Grant for Clinical Study of Measles and Rubella Vaccination
Funding Accelerates Vaxxas’ Clinical Pipeline of Innovative VaccinesVaxxas, a biotechnology company commercializing a novel vaccination platform, today announced that it has received a US$5 million [AU$7.5 . . .
Posted on 3/17/20
Sigilon Therapeutics Raises $80.3M Series B
Sigilon Therapeutics, Inc., a biotechnology company developing functional cures for patients with chronic diseases through its Shielded Living Therapeutics platform
Posted on 3/17/20
Thermo Fisher Scientific to Produce Millions of COVID-19 Test Kits in the Next Few Weeks
America's capacity to detect the coronavirus responsible for COVID-19 will get an enormous bump from Thermo Fisher Scientific (NYSE:TMO). The world's largest producer of scientific tools . . .
Posted on 3/16/20
Harvard T.H. Chan School of Public Health Collaborates with Thrive Global
BOSTON--(BUSINESS WIRE)--Building on its renowned commitment to support the public health community around the world, the Harvard T.H. Chan School of Public Health announced today the . . .
Posted on 3/16/20
AVEO Oncology Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today reported financial results for the full year ended December 31, 2019 and provided a business update.“The coming months will . . .
Posted on 3/16/20
Tetraphase Pharmaceuticals and AcelRx Pharmaceuticals To Merge
WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVA to treat serious and life-threatening infections, today announced the . . .
Posted on 3/16/20
Markel Announces Investment In Combined Lansing And Harvey Distribution Businesses
Markel Corporation (NYSE: MKL) announced today that it has entered into a definitive agreement to acquire a majority interest in Lansing Building Products. Simultaneously, Lansing entered . . .
Posted on 3/16/20
Leap Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended . . .
Posted on 3/16/20
AVROBIO Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today reported . . .
Posted on 3/16/20
Sesen Bio Reports Fourth Quarter and Full-Year 2019 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported operating results . . .
Posted on 3/16/20
2020’s Best & Worst States for Doctors – WalletHub Study
Doctors are one of the most essential professions, especially as the threat of coronavirus grows in the U.S. Doctors are on the front lines helping to . . .
Posted on 3/16/20
The Coronavirus Pandemic Will Delay 2020 IPOs
We've all had the fantasy. The one that entails buying into a newly public company early and getting rich as it goes on to crush the . . .
Posted on 3/16/20
Trial for a Coronavirus Vaccine to Start on Monday
The COVID-19 pandemic is getting worse, both in the U.S. and worldwide. According to the World Health Organization (WHO), as of March 15, there are more . . .
Posted on 3/16/20
Bill Gates Steps Down from Berkshire Hathaway and Microsoft Boards
Microsoft (NASDAQ:MSFT) co-founder, Bill Gates, has announced he is stepping down from his board of director roles with both Microsoft and Berkshire Hathaway Inc. (NYSE:BRK.A) (NYSE:BRK.B).Berkshire . . .
Posted on 3/16/20
The Vertex Foundation Donates $500,000 to Partners HealthCare to Support COVID-19 Outbreak Response
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the Vertex Foundation, a nonprofit charitable foundation, is making a $500,000 gift to Partners HealthCare, a Boston-based . . .
Posted on 3/13/20
Biogen and Vir Biotechnology to Collaborate to Find a Treatment for the Coronavirus
COVID-19 continues to spread worldwide. The latest situation report from the World Health Organization (WHO) shows that there are now more than 125,000 confirmed cases of . . .
Posted on 3/12/20
Ethismos Research Initiates $50 MM Private Placement Led by VENTURE.co Brokerage Services
Ethismos Research, developing pharmaceutical treatments for chronic pain management, severe depression, and substance use disorders, announced the initiation of a $50 million private placement, led by . . .
Posted on 3/12/20
Kymera Therapeutics Announces $102 Million Series C Financing
Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough protein degrader medicines for patients
Posted on 3/12/20
Carrum Health Partners with Northern Light Health
Carrum Health, the first digital health company connecting employers and employees with Centers of Excellence (COEs) for better, more cost-effective healthcare, today announced a new partnership . . .
Posted on 3/12/20
X4 Pharmaceuticals Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, . . .
Posted on 3/12/20
FDA Approves Bristol Myers Squibb's Liver Cancer Drug Combo
Bristol Myers Squibb (NYSE:BMY) announced on Wednesday that its liver cancer drug combo had officially received approval from the U.S. Food and Drug Administration. The Opdivo . . .
Posted on 3/12/20
Everbridge Stock Is Immune To The Coronavirus
SummaryEverbridge is one of only two digital transformation companies that are flourishing during the coronavirus scare.The stock price is up close to 20% over the last . . .

